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Abstract Nonsyndromic cleft lip and palate (NSCL/P) is a
complex disease resulting from failure of fusion of facial
primordia, a complex developmental process that includes
the epithelial-mesenchymal transition (EMT). Detection of
differential gene transcription between NSCL/P patients
and control individuals offers an interesting alternative for
investigating pathways involved in disease manifestation.
Here we compared the transcriptome of 6 dental pulp stem
cell (DPSC) cultures from NSCL/P patients and 6 controls.
Eighty-seven differentially expressed genes (DEGs) were
identified. The most significant putative gene network
comprised 13 out of 87 DEGs of which 8 encode
extracellular proteins: ACAN, COL4A1, COL4A2, GDF15,
IGF2, MMP1, MMP3 and PDGFa. Through clustering
analyses we also observed that MMP3, ACAN, COL4A1
and COL4A2 exhibit co-regulated expression. Interestingly,
it is known that MMP3 cleavages a wide range of
extracellular proteins, including the collagens IV, V, IX,
X, proteoglycans, fibronectin and laminin. It is also capable
of activating other MMPs. Moreover,MMP3 had previously
been associated with NSCL/P. The same general pattern
was observed in a further sample, confirming involvement
of synchronized gene expression patterns which differed
between NSCL/P patients and controls. These results show
the robustness of our methodology for the detection of
differentially expressed genes using the RankProd method. In
conclusion, DPSCs from NSCL/P patients exhibit gene
expression signatures involving genes associated with mecha-
nisms of extracellular matrix modeling and palate EMT
processes which differ from those observed in controls. This
comparative approach should lead to amore rapid identification
of gene networks predisposing to this complex malformation
syndrome than conventional gene mapping technologies.
Keywords Nonsyndromic cleft lip and palate .
Gene expression profile . Dental pulp . Stem cell .
Epithelial-mesenchymal transition . Extracellular matrix
Introduction
Nonsyndromic cleft lip and palate (NSCL/P [MIM 119530]),
a complex multifactorial disorder, is one of the most common
congenital malformations, with a prevalence of 0.69 to 2.35
per 1,000 births in the Caucasian population [1]. Taking
account of the complexities of this orofacial malformation
and the long rehabilitation period following surgery, cleft lip
and palate is considered to be a major psychosocial and
economic burden for families and society. Gaining insight
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into the genetic causes of NSCL/P should lead to future
improvement of genetic counseling, preventive and curative
measures.
The development of the human face begins with
migration of neural crest cells that combine with the core
mesoderm and pharyngeal ectoderm, establishing the facial
primordia, which in turn give rise to structures associated
with upper lip and palate formation [2, 3]. The growth,
differentiation and fusion of these structures are genetically
determined, and it is likely that disturbances in genetic
pathways orchestrating these processes result in facial
abnormalities, such as cleft lip and palate [2–5]. In this
context, the epithelial-mesenchymal transition (EMT) plays
a central role in generating the cranial neural crest cells as
well as ensuring palate and lip fusion [6–8].
The large number of genes known or suspected to be
involved in clefting probably reflects the diversity of
embryological events that contribute to the formation of
these facial structures [4, 9–16]. Although gene mapping
approaches, such as Genome-Wide Association Studies
(GWAS), appeared to offer an option to identify at-risk
alleles associated with NSCL/P, with better reproducibility
among different studies [10, 11, 17, 18] than candidate
genes, lack of progress over the last decade suggests that
GWAS are still unlikely to provide sufficient information
on the genetic etiology underlying the disease. However,
genome-wide expression analyses based on differential
gene expression associated with NSCL/P, as proposed here;
present a viable and challenging alternative, since patterns
of co-expression can be used to identify biological pathways
or gene networks associated with disease predisposition. The
current data supporting this supposition can be summarized as
follows: transcriptome analysis in tissues of cleft palate (CP)
patients showed a distinct gene expression signature when
compared to CL/P [19]. It has been reported that a few genes
coding for extracellular matrix proteins, such as TGFB3 and
MMP3, are differentially expressed in fibroblasts of NSCL/P
patients as compared to controls [20, 21], suggesting that the
transcriptome of NSCL/P cells might exhibit a specific
expression signature irrespective of origin of the cells
concerned.
The use of mesenchymal stem cells (MSCs) or induced
pluripotent stem cells (iPSs) has been shown to be a
promising new approach to study gene function and
signaling pathways in genetic disorders [22–24]. MSCs
constitute a long-lived population of cells possessing self-
renewal and differentiation properties [25–29]. Accordingly,
these cells are a good model to study the in vitro character-
istics of NSCL/P, since in addition to gene expression, they
can be tested for proliferation, migration and differentiation
properties, including EMT, functions that are presumed to be
altered in cells of NSCL/P patients during embryonic
development. MSCs were originally isolated from bone
marrow, and subsequently, similar cell populations were
isolated from other tissues, such as adipose tissue [27], dental
pulp [28, 30], orbicularis oris muscle [26], umbilical cord
blood, and umbilical cord tissue [31]. Moreover, MSCs can
be easily obtained from non-invasive sources, such as
exfoliated teeth, both from NSCL/P patients and control
individuals [28].
The main aim of this study was to verify if there are
consistent gene expression profile differences between
mesenchymal stem cells from NSCL/P patients and
controls. We chose to study stem cells from dental pulp as
they can be obtained relatively easy from both NSCL/P
patients and controls. In addition, these stem cells, as for
any other cells obtained from craniofacial tissues, are
derived from cranial neural crest cells which play an
important role in craniofacial development, including lip
and palate [32, 33]. Our results will provide a base line for
further investigation and insights into genetic pathway
irregularities associated with craniofacial clefts.
Materials and Methods
Sample: NSCL/P Patients and Controls
Ethical approval to obtain stem cells from dental pulp of
deciduous teeth was obtained from the Biosciences Institute
Research Ethics Committee (Protocol 037/2005). Samples
were included only after signed informed consent by the
parents or legal guardians.
Deciduous teeth from controls were obtained from
odontopediatric clinics in Sao Paulo, while teeth from
NSCL/P patients were excised during the exfoliation
period by Dr. Bueno D.F. at Sobrapar, Campinas, Sao
Paulo. An individual was classified as NSCL/P if no
other malformations than clefting of both lip and palate
were present.
We analyzed mRNA of dental pulp stem cell cultures
(DPSC) obtained from 6 controls and 6 NSCL/P patients
(Table 1, supplementary material) for microarray expression
analysis and for validation of 4 genes by quantitative Real-
Time PCR (qRT-PCR). Validation of the microarray
expression analysis by qRT-PCR for a larger number of
genes was also done in mRNA obtained from DPSC
cultures of 16 additional controls and 13 NSCL/P patients.
Stem Cell Culture
Stem cell cultures obtained from DPSC of deciduous
teeth were established according to previously published
protocols [28]. Cells were cultured at 37°C with 5% CO2
in DMEM-F12 (Invitrogen, UK) supplemented with 15%
Fetal Bovine Serum (FBS, HyClone, USA) and frozen in
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Table 1 List of 87 differentially expressed genes sorted out by comparing controls and NSCL/P patients with the RankProd analysis
AFFY ID Gene symbol FCa Pfpb Cytoband
8176375 RPS4Y1 5.1099 0.0007 Yp11.3
8176624 DDX3Y 4.9358 0.0000 Yq11
8041206 LBH 4.6707 0.0000 2p23.1
8118509 PPT2 c 4.2212 0.0008 6p21.3
7972750 COL4A1 d c 3.6284 0.0006 13q34
7932254 ITGA8 d c 3.2852 0.0037 10p13
8125537 HLA-DMA c 3.2541 0.0005 6p21.3
7998927 – 3.0562 0.0053 –
8108370 EGR1 3.0266 0.0124 5q31.1
8176719 EIF1AY 2.9797 0.0055 Yq11.222
7952205 MCAM d c 2.9129 0.0123 11q23.3
7953200 CCND2 2.7894 0.0089 12p13
8056491 SCN9A c 2.7724 0.0223 2q24
7964388 NDUFA4L2 2.7670 0.0112 12q13.3
8113504 C5orf13 2.7473 0.0077 5q22.1
8176578 USP9Y 2.7360 0.0219 Yq11.2
8104663 CDH6 d c 2.7285 0.0263 5p15.1-p14
7985786 ACAN d c 2.6889 0.0042 15q26.1
8121838 TPD52L1 2.6688 0.0106 6q22-q23
8177137 UTY 2.6455 0.0280 Yq11
7970033 COL4A2 d c 2.6123 0.0210 13q34
7965573 NTN4 c 2.5853 0.0129 12q22-q23
8003298 SLC7A5 c 2.5767 0.0174 16q24.3
8156783 COL15A1 c 2.5452 0.0250 9q21-q22
8090565 SNORA7B 2.5214 0.0225 3q21.3
7954293 PDE3A 2.5063 0.0121 12p12
8137670 PDGFA d c 2.4802 0.0179 7p22
8049888 ATG4B 2.4474 0.0115 2q37.3
7974895 FLJ43390 2.4260 0.0427 14q23.2
7958262 TCP11L2 2.4172 0.0253 12q23.3
7989985 ITGA11 c 2.4038 0.0447 15q23
8104035 SORBS2 2.3912 0.0291 4q35.1
8102800 SLC7A11 c 2.3697 0.0390 4q28-q32
7912157 ERRFI1 2.3596 0.0308 1p36
7981728 – 2.3590 0.0407 –
7985493 TM6SF1 2.3535 0.0442 15q24-q26
7981962 SNORD116-5 2.3518 0.0419 15q11.2
7931977 ITIH5 2.3354 0.0486 10p14
7928308 DDIT4 2.3277 0.0467 10pter-q26.12
8034940 NOTCH3 c 2.3234 0.0396 19p13.2-p13.1
7966089 CMKLR1 c 2.2946 0.0455 12q24.1
8068024 JAM2 d c 2.2538 0.0397 21q21.2
8023152 TCEB3CL 2.2139 0.0407 18q21.1
8109159 LOC728264 2.2134 0.0459 5q33.1
8117018 JARID2 2.2051 0.0408 6p24-p23
8086752 RNU13P3 2.2046 0.0452 3p21.31
7982868 CHAC1 2.2041 0.0273 15q15.1
8139207 INHBA c 2.1839 0.0405 7p15-p13
8027352 – 2.1608 0.0399 –
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40% FBS for storage. Frozen cells were thawed and grown
until 80% confluency in a 75 cm2 flask and submitted to
serum starvation (12 h) prior to RNA extraction. All
experiments were conducted with cells between the 4th
and 8th subculture.
Characterization of Mesenchymal Stem Cell Populations
Cell populations used in the microarray assays were
analyzed in a flow cytometer for specific cell surface
markers to evaluate homogeneity. Cells were harvested
Table 1 (continued)
AFFY ID Gene symbol FCa Pfpb Cytoband
8027002 GDF15 c 2.1594 0.0285 19p13.11
8048749 KCNE4 c 2.1436 0.0184 2q36.3
8007850 LRRC37A 2.0206 0.0244 17q21.31
8160138 NFIB 1.9790 0.0182 9p24.1
8131867 – 1.8907 0.0477 –
8064978 JAG1 d c 1.8529 0.0178 20p12.1-p11.23
8042788 ACTG2 1.7905 0.0414 2p13.1
8045804 – 1.7730 0.0492 –
8092726 CLDN1 d 1.4872 0.0445 3q28-q29
7937772 IGF2 −1.8634 0.0165 11p15.5
7915592 – −1.8745 0.0195 –
8124391 HIST1H2AB −2.0165 0.0426 6p21.3
8163202 SVEP1 −2.0970 0.0214 9q32
8037240 PSG1 c −2.1467 0.0273 19q13.2
8044605 LOC654433 −2.2491 0.0468 –
8117594 HIST1H2BM −2.2734 0.0128 6p22-p21.3
7951271 MMP1 d c −2.3465 0.0026 11q22.3
8138888 PDE1C −2.4348 0.0263 7p15.1-p14.3
8140668 SEMA3A c −2.5040 0.0042 7p12.1
7951284 MMP3 d c −2.5261 0.0433 11q22.3
8107044 ERAP2 −2.5407 0.0291 5q15
8003667 SERPINF1 c −2.5688 0.0109 17p13.1
8110916 LOC442132 −2.5879 0.0258 5p15.31
7904293 PTGFRN c −2.6619 0.0164 1p13.1
8113800 FBN2 c −2.7034 0.0000 5q23-q31
8116418 GFPT2 −2.8180 0.0212 5q34-q35
8152617 HAS2 d −2.8501 0.0038 8q24.12
8129573 MOXD1 c −2.8809 0.0181 6q23.1-q23.3
7925929 AKR1C3 −3.1055 0.0165 10p15-p14
7917850 ARHGAP29 −3.1793 0.0031 1p22.1
8037251 PSG7 c −3.2618 0.0006 19q13.2
8180291 – −3.2801 0.0006
8165808 XG c −3.6591 0.0065 Xp22.33
8037272 PSG5 // PSG5 c −3.7775 0.0000 19q13.2 // 19q13.2
8083887 CLDN11 d −4.2221 0.0000 3q26.2-q26.3
7909730 KCNK2 c −4.7183 0.0000 1q41
8037283 PSG4 c −4.9049 0.0000 19q13.2
8152522 ENPP2 d c −5.3472 0.0000 8q24.1
a FC = Fold change
b Pfp = estimated percentage of false positive predictions.
(c ) Genes that were functionally categorized as glycoproteins by DAVID (p=8,0E-6).
(d ) Genes involved in EMT.
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with TrypLe (Invitrogen, UK), washed with PBS, and
incubated at 4°C for 30 min with the following antibodies:
CD29-PE CY5, CD90 (Thy-1), CD45-FITC, CD31-PE
(Becton Dickinson, USA), SH2, SH3, and SH4 (Case
Western Reserve University, USA). After a second wash,
samples incubated with unconjugated primary antibodies
were then incubated with anti-mouse-PE secondary anti-
body (Guava Technologies, Hayward, CA) for an additional
15 min at 4°C. Finally, the cell suspension was washed with
PBS, and signals from 105 cells were acquired with an
EasyCyte Flow cytometer (Guava Technologies). Control
samples for determining background noise were incubated
with PBS instead of primary antibody followed by
incubation with anti-mouse-PE secondary antibody. All
plots generated were analyzed with Guava ExpressPlus
software (Guava Technologies).
The in vitro differentiation into bone, cartilage, muscle
and fat had previously been demonstrated in 2 of the
NSCL/P patients (F4280, F4285) and 3 of the control
(F3363, F4271, F4272) samples included in this study [28,
29]. Because of the high reproducibility of our protocols,
stem cell cultures are currently characterized only with
respect to their immunophenotype.
RNA Processing
Total RNA was isolated using TRIzol (Invitrogen, UK)
according to the manufacturer’s protocol and purified with
RNeasy Mini-kit (QIAGEN). RNA quality and concentration
were assessed using Nanodrop 1000 and gel electrophoresis.
Only samples with a preserved rRNA ratio (28S/18S) and no
evidence of RNA degradation were used in the microarray
hybridization and qRT-PCR.
Microarray Processing
Expression measurements were performed using the Affy-
metrix Human Gene 1.0 ST array, which interrogates
28,869 genes, following RNA labeling and hybridization
protocols as recommended by the manufacturer. After array
scanning, quality control was performed with GCOS
software (Affymetrix, USA) according to the manufacturer’s
recommendations.
Transcriptome Analysis
Gene expression values were obtained using the three-step
Robust Multi-array Average (RMA) pre-processing method,
implemented in the Affy package from R/Bioconductor [34].
We employed the RankProd method for the selection
of differentially expressed genes (DEGs), considering a
p-value cut-off of 0.05 adjusted for FDR (False Discovery
Rate) [35]. RankProd is a rank-based nonparametric proce-
dure [36]. The method has the advantage of being able to
deal with few samples for identifying biologically relevant
expression changes [37]. Genes selected by RankProd do not
necessarily need to present homogenous expression levels
across all the samples of the test and control groups.
Accordingly, RankProd seems to be a good choice for
identifying differential gene expression in complex diseases,
in which altered expression of a given candidate gene is
expected in just a subgroup of patients due to both multi-
locus genetic heterogeneity and the stochastic nature of gene
expression in complex systems [38].
Functional Annotation
We performed functional annotation analysis of the
differentially expressed genes with the DAVID (Database
for Annotation, Visualization and Integrated Discovery,
http://david.abcc.ncifcrf.gov) and IPA (Ingenuity Pathway
Analysis, http://www.ingenuity.com) tools. In IPA, we
considered the default parameter Molecules per Network=
35, Networks per Analysis=25, only direct relationships
between genes and the “Ingenuity Expert Information”
Data Source, including the new option of “Ingenuity
ExpertAssist Findings”, in which the information has
been manually reviewed and curated from full-text scientific
publications.
Validation of Microarray Expression Using Quantitative
Real-Time PCR (qRT-PCR)
Initially we performed qRT-PCR for 4 genes (COL15A1,
ERAP2, PPT2 and EGFL8) on the same samples used in
the microarray assay. These genes were randomly selected,
but they were amongst those with the highest fold change.
PPT2 and EGFL8 are represented by a common probe set
on the Affymetrix Human Gene 1.0 ST array and therefore
both genes were tested for qRT-PCR with gene-specific
primers. Next, we performed qRT-PCR for further 12 genes
(ACAN, CDH6, CLDN1, CLDN11, COL4A1, COL4A2,
ENPP2, HAS2, ITGA8, JAG1, MCAM and MMP3) plus
the genes COL15A1, ERAP2 and PPT2 in 16 controls and
13 NSCL/P patients. Only 4 of the control and 4 of the
NSCL/P patients samples were the same as those used in
the microarray assay due to unavailability of RNA from
the remaining 4 individuals (Table 1 in supplementary
material).
One microgram of total RNA from each cell culture
was reverse transcribed with Superscript II (Invitrogen,
UK), according to manufacturer’s recommendations.
Quantitative Real-Time PCR reactions were performed
in duplicates with a final volume of 20 μl, using 20 ng
of cDNA, 1X SYBR Green PCR Master Mix (Applied
Biosystems) and 100–400 nM of each primer. We used
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ABI Prism 7500 Sequence Detection System (Applied
Biosystems) with standard temperature protocol. Primers
were designed with Primer Express software V.2.0
(Applied Biosystems; primers sequence in supplementary
Table 2) and the amplification efficiency (E) of each primer
was calculated according to the equation E=10 (−1/slope).
The expression data of the target transcripts were determined
by relative quantification in comparison to a pool of RNAs
(4 controls and 4 patients). GeNorm v3.4 was used to
determine the most stable endogenous controls (SDHA,
HPRT1 and GAPDH) and to calculate the normalization
factors for each sample [39]. Expression values were
calculated according to reference [40].
To compare the expression of COL15A1, ERAP2, PPT2
and EGFL8, obtained by qRT-PCR and microarray assay in
the same samples, we used an unpaired t-test with Welch’s
correction.
To compare the results obtained by microarray with
those obtained by qRT-PCR in the novel samples, for which
we do not have microarray data, we performed the
following strategy: for each of the 15 genes, we calculated
the average (avg) expression for controls and for NSCL/P
patients obtained by both methods (Table 3 in supplementary
material). The correlation between the ratios “avg_patients/
avg_controls” from microarray and qRT-PCR assays was
calculated using Spearman’s correlation test.
Clustering Analysis
The cluster analysis of the differentially expressed genes
was performed using GEDI (Gene Expression Dynamics
Inspector) software. This tool creates a 2 dimensional gene
expression image for each sample in which each gene
retains exactly the same position in the image of each
sample and in which the gene positions are computed to
give the most parsimonious gene arrangement for depicting
expression level differences between the patient and
control groups for all differentially expressed genes
[41]. In the analysis, a 10×11 grid configuration of SOM
(Self-Organizing Map) was used. Inspection of GEDI
images allows a straightforward classification of the
samples into subgroups without the aid of a clustering
algorithm, but simply based on the visual differences in
the patterns [42].
We also used two other conventional clustering
methods: K-means and Hierarchical, both available in
the MeV (MultiExperiment Viewer) software [43], with
Spearman’s correlation as the distance metric. The
clustering analysis of qRT-PCR data followed two criteria:
a) only DEGs from network 1 (Fig. 4) and b) only DEGs
that showed the same tendency of expression in the qRT-
PCR and microarray assays (Fig. 2 in supplementary
material).
Results
Characterization of Mesenchymal Stem Cell Populations
The cell cultures presented positive labeling for cell
adhesion (CD29, CD90) and mesenchymal stem cell
markers (SH2, SH3, SH4) in most of the cells (>90%)
and were negative for endothelial and hematopoietic cell
markers (Fig. 2 in supplementary material). Moreover, 2
NSCL/P patients and 3 control cell cultures used in the
microarray analyses had been previously shown to differ-
entiate into bone, muscle, cartilage and fat upon in vitro
induction [28, 29]. Therefore the cell populations used in
this study had the main properties of stem cells.
Controls versus NSCL/P Patients
We identified a total of 87 differentially expressed genes
(DEGs; 58 upregulated and 29 downregulated) in the
comparison between controls and NSCL/P patients (adjusted
p≤0.05; Table 1).
Next, in order to visualize the expression behavior of
these DEGs, we performed clustering analysis with the
GEDI software. An image was created reflecting the 87
DEGs’ transcriptional behavior for each individual and
where the gene position was fixed to give the most
parsimonious arrangement to show differential gene
expression between controls and NSCL/P patients. Upon
visual inspection of the GEDI images, we observed that
4 of the NSCL/P patients showed a similar expression
pattern (F4280, F4281, F4282, F4283; Fig. 1).
The clustering analysis with the k-means method
resulted in 9 gene clusters. Four of them exhibited a similar
expression profile among NSCL/P patients, most particu-
larly in the afore-mentioned group (F4280, F4281, F4282,
F4283; Fig. 2). The similarities and dissimilarities in
expression levels observed between NSCL/P patients were
similar for both clustering methods. The expression pattern
found in 4 out of 6 NSCL/P patients illustrates the
characteristic of RankProd of being capable of selecting
genes with differential expression in just a subgroup of
samples.
Functional Annotation
Differentially expressed genes were functionally annotated
and analyzed with two different tools. First, the DAVID
tool led to identification of three main canonical pathways
from the KEGG Database: Focal adhesion, Cell adhesion
molecules and ECM-receptor interaction (Fig. 3, 4 and 5 in
supplementary material). Moreover, the most relevant
functional category identified through DAVID was that of
Glycoproteins (p=8.0E-6), which included 36 of the 87
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DEGs (Table 1). Subsequently, the IPA tool was used to
characterize the 87 DEGs regarding possible biological
functions. We observed 3 relevant functions enriched with a
significant number of our genes: Cellular movement (20
genes, p=6.4E-06–2.76E-02), Cellular growth and prolifer-
ation (27 genes, p=3.11E-05–2.68E-02) and Cellular
development (27 genes, p=3.3E-05–2.47E-02) (Table 4 in
supplementary material). A putative network with the
largest number of DEGs built by IPA (13 DEGs; Fig. 4)
suggests functional relationship among several extracellular
proteins: ACAN, COL4A1, COL4A2, GDF15, IGF2,
MMP1, MMP3 and PDGFa. All of these 8 genes are
DEGs.
Validation of the Microarray Analysis
The reproducibility of gene expression assayed by Affymetrix
microarrays is high [44] and 4 genes (COL15A1, ERAP2,
PPT2 and EGFL8) were initially selected for validation
through qRT-PCR. Except for ERAP2 (p=0.0397), that
showed lower expression levels, the other genes showed
higher transcript levels in NSCL/P patients than in controls:
PPT2 (p=0.0087) and COL15A1 (p=0.0355) (Fig. 3), which
confirms the expression patterns observed in the microarray
assays. EGFL8 is represented by the same probe set of PPT2.
Considering that we did not find significant differential
expression levels through qRT-PCR with specific primers
Fig. 2 Gene clusters 1, 4, 6 and 9 resulted from k-means method
(k=9). In both clusters it is possible to observe a similar gene
expression profile among 4 out of 6 patients (F4280, F4281, F4282
and F4283), indicating that many of the 87 selected DEGs are co-
regulated in these 4 NSCL/P patients
Fig. 1 Clustering of 87 DEGs resulted from the comparison between 6
controls and 6 NSCL/P patients. Each GEDI map (or mosaic) represents
a gene expression profile of a single individual. The blue color
represents the lowest expression level and red color represents the
highest expression level on a scale of −4.70 to 7.98, respectively. The
black frame highlights four patients with similar gene expression profile
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for EGFL8 (p=0.1781), we kept only PPT2 among our
candidate genes.
For further validation of our results, in addition to
COL15A1, PPT2 and ERAP2, we analyzed a further 12
other genes known to be involved with matrix remodeling
in a novel sample of individuals (16 controls and 13 NSCL/P
patients). By comparing the ratios of the average expression
from patients/controls, we observed that ENPP2
exhibited the highest discordance between the microarray
and qRT-PCR ratios (0.645 and 4.324, respectively),
therefore we considered this gene expression as not
validated. However, we observed a significant positive
correlation between microarray and qRT-PCR expression
data (p=0.0114, r=0.653) for the 14 genes chosen for
validation (Table 3 in supplementary material). Accordingly,
the analyses thus show that the data obtained from
microarrays and qRT-PCR are consistent with each other, even
in an enlarged novel sample, attesting to the reliability of the
microarray analysis.
Using NSCL/P patients expression data from qRT-PCR
(13 NSCL/P patients) and microarray assays (6 NSCL/P
patients), we also performed a clustering analysis for the
following DEGs: ACAN, COL4A1, COL4A2, ERAP2,
HAS2, and MMP3. These genes belong to network 1
(Fig. 4) and exhibited the same expression tendency in both
experiments (Fig. 2 in supplementary material). The
hierarchical clustering performed with qRT-PCR data
Fig. 4 The most significant
network built by IPA tool
with the highest number of
differentially expressed genes.
The upregulated genes in
NSCL/P patients are indicated in
red and the downregulated
genes in green. The blank
symbols pertain to genes that
were either not present in our
array or not differentially
expressed. Solid lines indicate a
direct linkage among two genes.
Lines with arrows indicate that
one gene acts on the other, and
lines without arrows indicate
that the corresponding proteins
interact with each other. The 6
genes circled in orange were
used in clustering analysis of
qRT-PCR and microarray
Fig. 3 Quantitative Real-Time PCR (qRT-PCR) initial analysis of
NSCL/P patients and control samples for ERAP2, PPT2,
COL15A1. E = primer amplification efficiency; CT = cycle
threshold; delta_CT = sample’s average_CT normalized by pool’s
average_CT; NF = normalization factor
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revealed a homogeneous cluster with 7 out of 13 NSCL/P
patients (F4312, F4311, F4281, F4243, F4388, F5398 and
F4280), in which MMP3 is downregulated and ACAN,
COL4A1 and COL4A2 upregulated. ERAP2 and HAS2 did
not exhibit a consistent expression pattern in these patients
(Fig. 5a). Interestingly, the hierarchical clustering using
microarray data showed the same transcriptional behavior
among these genes in 4 out of 6 NSCL/P patients (F4280,
F4281, F4282 and F4283), although in this case, ERAP2
and HAS2 seem to be co-regulated with MMP3 and
collagens (Fig. 5b). Spearman’s correlation test (Fig. 5c)
calculated for each relationship among the genes from
Fig. 5a confirmed that MMP3 and ACAN are negatively
correlated (r=−0.889; p<0.05) while ACAN exhibited
positive correlation with COL4A1 and COL4A2 (r=0.921
and r=0.872, respectively; p<0.05), corroborating our
findings thus far. On the other hand, we did not achieve
significance for ERAP2 and HAS2, confirming the lack of a
well-defined expression pattern for these genes, as observed
in Fig. 5a.
Discussion
In this study, we conducted the first comparative tran-
scriptome analysis between dental pulp stem cells from
NSCL/P patients and controls to obtain more information
on the genetic etiology of this malformation and explore
new possibilities to identify pathways associated with
disease pathology.
Genome expression microarray analysis is a powerful
tool for assessing changes in the transcription patterns of
related genes and identification of signaling pathways
associated with specific cell types, culture conditions or
disease states [45, 46]. Considering that the cell populations
from NSCL/P patients and controls were established and
maintained under similar identical conditions, it is very
likely that a large proportion of the DEGs identified is
related to the genetic constitutional differences between
cells from NSCL/P patients and controls. The observations
that NSCL/P disease-specific expression profiles have also
been previously reported in tissue biopsies and fibroblast
cultures [19, 21] suggests that such profiles may be
ubiquitous; in this respect our findings suggest that the
disease-specific transcription profile is also present in
mesenchymal stem cells. Accordingly, transcriptome analysis
of stem cells represents an additional option to the study of the
transcriptome and genetics of NSCL/P.
Of the 87 DEGs obtained in our microarray analysis, we
noted that MMP3 had previously been proposed as a
candidate gene for NSCL/P [47]. A further 2 genes,
PDGFa and ERRFI1, had previously been indirectly
associated with NSCL/P, since their receptors, respectively
PDGFR and EGRF, were identified as predisposing loci for
this form of clefting [48–50]. These observations provide
further confirmation that the transcriptome of DPSCs from
NSCL/P patients can also be used to identify genetic
variations associated with the disease.
The functional annotation through DAVID showed that
nearly half of the 87 DEGs correspond to glycoprotein
molecules, including collagens, metalloproteinases, integrins,
and adhesion proteins, which are important to orchestrate the
signaling between the extracellular and intracellular compart-
ment. Indeed, the three canonical pathways we identified
through DAVID are mainly related to extracellular matrix
components and signaling molecules located on the cell
membrane (Fig. 3, 4 and 5 in supplementary material).
Functional relationships among several extracellular proteins
that are deregulated in our studies are also suggested by the
putative network built by IPA (Fig. 4). These analyses
suggest that a large proportion of the DEGs in the DPSC
from NSCL/P patients are extracellular matrix components
(ECM) involved in several cellular processes in facial
development, such as extracellular remodeling during the
epithelial-mesenchymal transition (EMT).
Fig. 5 Hierarchical clustering of all the patients analyzed by qRT-PCR
andmicroarray, considering only the genes from IPA network 1 (Fig. 4). a
Clustering of expression values obtained by qRT-PCR. b Clustering of
expression values obtained by microarray. c Correlations (Spearman’s
correlation test, r and p-values) between each co-regulated gene from
qRT-PCR clustering. It is possible to observe that the gene MMP3 is
significantly and inversely correlated to ACAN, COL4A1, COL4A2
genes in a subgroup of patients from qRT-PCR. This same pattern of co-
regulation is also present in another group of patients analyzed by
microarray, which includes two individuals (F4280 and F4281) from the
mentioned qRT-PCR subgroup. In controls expression data of both
assays, MMP3 is upregulated and ACAN, COL4A1 and COL4A2
downregulated
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EMT is a fundamental mechanism behind palatal fusion.
This process occurs through a regulated sequence of events
determined both by the extracellular environment and the
gene expression program of the cell, leading to loss of cell-
cell adhesion, breakdown of basal laminae, and increased
cell invasion and mobility [51, 52].
Fifteen genes enrolled in EMT are within the 87 DEGs
(Table 1). Further, we observed the enrichment of biological
functions involving cell proliferation, movement and invasion
(Table 4 in supplementary material), all of which are expected
phenotypic outcomes for genes involved with EMT.
In the most relevant IPA network we observed that 8 out
of 13 DEGs (ACAN, COL4A1, COL4A2, GDF15, IGF2,
MMP1, MMP3 and PDGFa, Fig. 4) are extracellular matrix
components, suggesting that an abnormal expression
behavior of these genes may affect EMT during palate
development.
Clustering analyses showed that MMP3, ACAN,
COL4A1 and COL4A2 transcripts are co-regulated in 4
out of 6 NSCL/P patients analyzed by microarray as well as
in 7 out of 13 NSCL/P patients from qRT-PCR analysis.
Therefore, it seems that in NSCL/P mesenchymal cells, the
down-regulation of MMP3 is associated with up-regulation
of ACAN, COL4A1 and COL4A2. Such a deregulated
pathway probably has serious consequences in embryonic
development, since it is known that the MMP3 protein
cleaves a wide range of ECM proteins, including the
collagens IV, V, IX, X, proteoglycans, fibronectin and
laminin. It is also capable of activating other MMPs, as
shown in network 1 (Fig. 4), and playing a key role in ECM
degradation and remodeling [47]. In this context it has
already been experimentally shown that lower levels of
MMPs can block palatal fusion [7]. Therefore, it is possible
that failure of lip and palate fusion in these groups of
patients is at least partly associated with down-regulation of
MMPs and up-regulation of collagens. It will be important
in the near feature to identify the leading causative
mechanism of altered expression of MMPs in these
individuals. These results also show the robustness of
RankProd to detect DEGs on a limited and heterogeneous
group of samples, in contradistinction to a popular method
SAM [53] which appears to require larger sample sizes.
Moreover, RankProd is able to identify expression
patterns in just a subgroup of affected samples, which
is the ideal, considering that this is the expected to
occur in a complex disease such as NSCL/P. Notwith-
standing our favorable impression of RankProd, we are
acutely aware of the small sample sizes employed in
detecting DEGs in the initial microarray assay. Future
studies must be directed towards confirming and/or
expanding the pattern of DEGs using novel and much
larger sample sizes.
In summary our results suggest that NSCL/P patients
exhibit deregulation of genes participating in either
EMT or embryonic processes that depend on extracel-
lular modeling. Abnormal expression of some genes
encoding for extracellular matrix proteins in NSCL/P
fibroblasts has also been reported by others, reinforcing
the concept that disease expression signatures for
NSCL/P are present in various tissues and not neces-
sarily confined to a specific cell type. Moreover, the
penetrance of the phenotype can depend on exposure to
environmental factors and it is of interest that a recent
report claimed a positive association between nicotine
exposure and the CL/P phenotype in conjunction with
deregulation of gene expression involved in ECM
synthesis and degradation [21].
The observation that the DEGs in NSCL/P patients are
associated with ECM component signaling suggests that
further analysis of these cells presents unique opportunities to
study the complexity of molecular pathways and alleles
involved in NSCL/P etiology. However, arguably the major
advantage of DPSCs above other cell types, such as
fibroblasts, will be their potential to study in vitro differen-
tiation into muscle, bone and cartilage that are affected
tissues in NSCL/P. In this context, it will be possible to
integrate genomic and transcriptome analysis under different
experimentally induced environmental insults on identical
cell cultures. Our results open new avenues for the study of
novel candidate genes for NSCL/P, since most of the 87
DEGs have not been previously associated with NSCL/P. In
particular, the potential offered by our approach can be best
visualized in the gene network 1 (Fig. 4), in which several of
our DEGs are ECM components, suggesting that these genes
might be enrolled in EMT during the development of NSCL/
P phenotype.
If wide-spread differences in co-regulated gene tran-
scription, as observed in our experiments, are indeed a
primary cause of NSCL/P, then the research emphasis must
move away from naively cataloging which genes are being
differentially expressed to defining the central transcription
factors and regulatory elements that are driving the disease
specific transcription patterns. In this respect, identifying
the putative gene networks involved, as in our observations,
will be an initial crucial step towards defining which
regulatory elements are the most important.
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